A closer look at the technology, treatment model, practice fit, and potential role of pelvic health inside a modern med spa.
Product photo shown for identification purposes.
The Gazelle Pelvic Floor Chair is positioned around a simple idea: give practices a way to offer pelvic health services without adding an invasive treatment format to their menu. It's a seated, fully-clothed electromagnetic stimulation device, and for many practices it represents an entirely new service category rather than an upgrade to an existing one. Because pelvic floor concerns cut across age groups and both post-partum and general wellness contexts, Gazelle is often framed less as a single device purchase and more as a decision to add pelvic health as a business line.
The chair delivers electromagnetic stimulation to the pelvic floor musculature while the patient remains fully clothed and seated, aiming to induce repeated muscle contractions similar in principle to targeted pelvic floor exercise, without the patient needing to actively perform anything during the session.
Gazelle uses ExMI (Extracorporeal Magnetic Innervation) technology, a category with a history of use in continence and pelvic health settings. The magnetic field passes through clothing and tissue to stimulate the pelvic floor muscles directly, without any internal probe or invasive component — a meaningful difference from some clinical pelvic health devices that require internal placement.
Practices most often position this toward adults with mild to moderate pelvic floor concerns, post-partum patients seeking core and pelvic recovery support, and wellness-motivated patients interested in a non-invasive preventive option. As with any device in this category, appropriate candidacy should be assessed using the practice's own clinical judgment and current labeling.
Patients remain seated and fully clothed for the entire session. This is one of the device's most frequently cited advantages in practice marketing: there's no undressing, no internal treatment component, and no topical numbing required, which can lower the hesitation some patients feel about pelvic health services generally.
| Technology | ExMI (Extracorporeal Magnetic Innervation) |
|---|---|
| Treatment Time | A single session is generally described as a short, in-office visit; exact per-session length should be confirmed with Gazelle for current protocols. |
| Downtime | None |
| Dimensions | Verification Pending |
| Weight | Verification Pending |
| Power Requirements | Verification Pending |
| Warranty | Confirm current warranty and service terms directly with Gazelle at time of purchase. |
Generally positioned as operable by trained clinical or aesthetic staff under practice protocols; confirm current provider/supervision requirements for your state and license type.
Practice fit: Small, Medium, Multi-location
Consumables: No. Chair-based delivery with no disposable applicators identified in current published materials.
Manufacturer-provided onboarding training is typically offered at purchase; confirm current training format and duration with Gazelle.
Because there's no disposable consumable identified in current published materials, per-treatment margin can be favorable once the device is paid down — though the capital cost, patient education investment, and time to build category awareness should all be modeled into a realistic timeline (see the ROI calculator in our buying guide). Use our device ROI calculator to model this against your own local pricing and volume assumptions.
Pelvic health is a differentiated story most local competitors aren't telling yet, which can be a genuine marketing advantage — but it also means practices typically need to invest more in patient education content than they would for a widely-understood category like laser hair removal.
Electromagnetic pelvic floor stimulation (ExMI) is an established technology category with a growing body of published research in pelvic health and continence literature. Device-specific clinical evidence for Gazelle should be requested directly from the manufacturer before being cited in patient-facing materials. Electromagnetic pelvic floor stimulation as a technology category has a developing base of published research in pelvic health and continence literature. We have not independently reviewed device-specific clinical studies for Gazelle; request current study citations directly from the manufacturer before using specific claims in patient materials. Evidence Verification Pending
Electromagnetic pelvic floor stimulation devices, as a technology category, are commonly marketed as FDA-cleared for specific indications. Confirm Gazelle's specific current clearance and indicated uses directly with the manufacturer before making clinical or marketing claims. Confirm Gazelle's specific, current FDA clearance and indicated uses directly with the manufacturer. Electromagnetic pelvic floor stimulation devices, as a category, are commonly marketed under specific cleared indications — the exact scope varies by manufacturer and model and should never be assumed. Regulatory Status: Verification Pending
Practices exploring pelvic health, post-partum recovery support, and continence-adjacent wellness services as a new, non-invasive category.
A combined radiofrequency and electromagnetic muscle stimulation platform marketed for simultaneous fat and muscle-focused body contouring.
Gazelle is best evaluated as a decision about entering a new service category, not simply a device purchase. Practices that do well with it tend to be the ones willing to invest in patient education and a clear referral or awareness pathway, rather than expecting existing demand to show up on its own.
We have not yet independently verified the current, specific FDA clearance for the Gazelle Pelvic Floor Chair. Electromagnetic pelvic floor stimulation devices, as a technology category, are commonly marketed as FDA-cleared for specific indications. Confirm Gazelle's specific current clearance and indicated uses directly with the manufacturer before making clinical or marketing claims.
Patient downtime for this device is generally described as None. Individual results and recovery can vary by patient and protocol.
Consumables are listed as No: Chair-based delivery with no disposable applicators identified in current published materials. Confirm current consumable pricing directly with Gazelle before modeling margins.
